At Andrología Mallorca, we study each case individually in order to offer the best treatment for benign prostatic hyperplasia to each patient.
The main goal of treating Benign Prostatic Hyperplasia is to manage prostate growth and relieve associated symptoms.
Benign prostatic hyperplasia may be linked to modifiable factors, such as certain lifestyle habits or the use of medications. These factors are usually addressed before starting specific treatment or in conjunction with it.
The purpose of oral medications is to relieve symptoms associated with prostate enlargement. In mild cases, these drugs improve urinary flow and enhance the patient’s quality of life.
While oral medications are often effective for mild cases of hyperplasia, their effectiveness may vary depending on the degree of prostate growth and the individual characteristics of each patient. For this reason, it is essential to follow medical advice and undergo appropriate follow-up.
There are several types of oral medications to treat benign prostatic hyperplasia (BPH), which fall into two main categories: alpha-blockers and 5-alpha-reductase inhibitors.
The choice of the appropriate drug may depend on several factors, such as individual response to the medication, duration of action, tolerability, cost, and convenience. Here is a brief description of some of the most common drugs.
Alpha-blockers help relax the muscles in the prostate and bladder, facilitating urinary flow.
Among the most common are Tamsulosin (Omnic Ocas), Alfuzosin (Unibenestan), Silodosin (Silodyx), Terazosin (Alfaprost) and Doxazosin (Carduran).
These medications work by reducing the size of the prostate by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth.
Among the most common are Finasteride (Proscar) and Dutasteride (Avodart).
Some treatments combine both types of medication to address benign prostatic hyperplasia (BPH) from different perspectives, improving symptoms more comprehensively.
An example of a combination treatment is the combination of Tamsulosin and Dutasteride (Duodart). This option combines an alpha-blocker and a 5-alpha-reductase inhibitor in a single tablet, offering a comprehensive solution that reduces prostate size and improves urinary flow. The alpha-blocker provides faster symptomatic relief, while the 5-alpha-reductase inhibitor contributes to long-term prostate size reduction.
This combination may be more effective for some patients, especially those with moderate symptoms or who have not responded adequately to a single type of medication.
At Andrology Mallorca, we emphasise the importance of consulting with a urologist to tailor treatment to each patient’s specific needs. Our team is committed to offering personalised solutions to ensure the best management of benign prostatic hyperplasia.
At Andrology Mallorca, we will study your case and offer you personalised treatment according to your needs and preferences. Contact us and we will answer all your questions and queries.